Blood-Based Biomarkers of Aging and Neurodegeneration in Longitudinal Cohort Studies of Brain Aging

Abstract

Alzheimer’s disease and related dementias (ADRD) have a long preclinical stage, with early pathological brain changes starting often in midlife, decades before any clinical symptoms. Identifying individuals at risk for cognitive and physical decline early will thus be most effective for intervention and prevention methods.